Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,778 filings

Top spenders & firms Spend by issue

Clear
Q1
ACG ADVOCACY for WALGREEN CO.
1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Pharmacy, Taxation/Internal Revenue Code, Medicare/Medicaid, Insurance
View →
Q1
THE METROHEALTH SYSTEM for THE METROHEALTH SYSTEM
1st Quarter (Jan 1 - Mar 31) 2025 · Ohio · House · Senate
Medicare/Medicaid, Health Issues, Budget/Appropriations, Pharmacy
View →
Q1
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View →
Q1
TIDAL BASIN ADVISORS, INC. for YC CONSULTING, LLC ON BEHALF OF DISPOSE RX, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $20,000.00 income
Health Issues, Pharmacy
View →
Q1
TIDAL BASIN ADVISORS, INC. for YC CONSULTING, LLC ON BEHALF OF PATIENTS RISING NOW
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $10,000.00 income
Copyright/Patent/Trademark, Defense, Health Issues, Pharmacy
View →
Q1
FORWARD GLOBAL for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · $20,000.00 income
Pharmacy, Health Issues
View →
Q1
EMD SERONO, INC. for EMD SERONO INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Science/Technology, Trade (domestic/foreign), Health Issues, Medicare/Medicaid
View →
Q1
LONG STRATEGIES, INC. for YC CONSULTING, LLC ON BEHALF OF PATIENTS RISING NOW
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $10,000.00 income
Copyright/Patent/Trademark, Defense, Health Issues, Pharmacy
View →
Q1
RUBICON ADVISORS, LLC for IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · $45,000.00 income
Pharmacy
View →
Q1
RUBICON ADVISORS, LLC for ALZHEON
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · $12,000.00 income
Pharmacy
View →
Q1
RUBICON ADVISORS, LLC for HYPOPARATHYROIDISM ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · California
Pharmacy
View →
Q1
RUBICON ADVISORS, LLC for ASCENDIS PHARMA, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · $60,000.00 income
Pharmacy
View →
Q1
BRUMIDI GROUP for PUBLIX SUPER MARKETS
1st Quarter (Jan 1 - Mar 31) 2025 · Florida · House · Senate · $40,000.00 income
Financial Institutions/Investments/Securities, Agriculture, Pharmacy, Food Industry (safety, labeling, etc.)
View →
Q1
RUBICON ADVISORS, LLC for DR. REDDY'S LABORATORIES, LTD
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate · $60,000.00 income
Pharmacy
View →
Q1
TWENTY-FIRST CENTURY GROUP, INC. for CARDINAL HEALTH, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Ohio · House · Senate · $24,000.00 income
Health Issues, Pharmacy, Disaster Planning/Emergencies, Budget/Appropriations
View →
Q1
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS
1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q1
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate
Alcohol and Drug Abuse, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q1
DLA PIPER LLP (US) for XEROX HOLDINGS CORPORATION
1st Quarter (Jan 1 - Mar 31) 2025 · Kentucky · House · Senate · $40,000.00 income
Pharmacy
View →
Q1
ARTEMIS POLICY GROUP LLC for NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION)
1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues, Insurance, Budget/Appropriations
View →
Q1
VANDERBILT UNIVERSITY MEDICAL CENTER for VANDERBILT UNIVERSITY MEDICAL CENTER
1st Quarter (Jan 1 - Mar 31) 2025 · Tennessee · House · Senate
Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q1
ARTEMIS POLICY GROUP LLC for THE HEMOPHILIA ALLIANCE
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $40,000.00 income
Medicare/Medicaid, Insurance, Pharmacy
View →
Q1
DLA PIPER LLP (US) for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Health Issues, Medicare/Medicaid, Budget/Appropriations
View →
Q1
DLA PIPER LLP (US) for CURRAX PHARMACEUTICALS LLC
1st Quarter (Jan 1 - Mar 31) 2025 · Tennessee · House · Senate · $60,000.00 income
Pharmacy
View →
Q1
CAPITOL COUNSEL LLC for PCCA, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House · Senate · $40,000.00 income
Pharmacy
View →
Previous Page 61 of 72 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem